Syno One Plus Rapid-Onset Dual-Action Analgesia for Acute & Chronic Joint Pain

The complementary onset profiles of the two active components — immediate corticosteroid action within hours and progressive HA benefit over weeks — deliver a pain control curve uniquely suited to the variable, episodic nature of chronic joint pain.

Corticosteroid component delivers clinically meaningful pain reduction within 24–48 hours of injection, providing immediate relief for patients with high acute pain burden. HA component produces progressive, cumulative pain reduction reaching peak effect at 4–8 weeks and sustained through 26 weeks in clinical trial populations. Combined VAS score reductions significantly exceed those achieved with either component alone, demonstrating additive analgesic synergy between the two active ingredients. Post-injection analgesic sparing allows clinicians to initiate planned dose reduction of systemic analgesics from week one, supporting safer long-term pain management.

Optimal for patients with moderate-to-severe joint pain where rapid symptom control is clinically necessary — including pre-operative optimisation and post-exacerbation rescue therapy. Integration into structured pain management plans is recommended; injection should be coordinated with physiotherapy initiation to maximise functional rehabilitation gains. Minimum three-month retreatment interval; treatment plan review at six weeks recommended to assess analgesic response and plan subsequent pain management steps. Special consideration required in patients with adrenal suppression risk; full corticosteroid precaution protocol applies as per standard injectable steroid guidelines.